等待開盤 09-09 09:30:00 美东时间
-1.965
-18.35%
Tonmya, a sublingual cyclobenzaprine HCl tablet, was approved by the FDA on August 15, 2025, as the first new treatment for fibromyalgia in over 15 years. Studies showed Tonmya significantly reduced pain, improved sleep, and decreased fatigue compared to placebo, with a favorable tolerability profile. It is expected to be available in the fourth quarter of 2025. Tonmya works by targeting sleep disturbances linked to fibromyalgia symptoms through ...
09-08 11:00
TON Strategy Company ( ($TONX) ) has shared an announcement. On September 5, 20...
09-06 05:30
Video and slides of Executive Chairman Manuel Stotz's first Chairman's Message now available onlineRemarks lay out vision to exceed 5% of TON supply, expand staking revenues, and consider pursuing tokenization of the
09-06 05:02
TON Strategy Company, now trading as TONX on Nasdaq, focuses on accumulating Toncoin ($TON) for long-term investment and benefits from its native integration into Telegram's billion-user platform. The Company aims to support the development of a tokenized economy within Telegram while continuing its legacy businesses.
09-04 12:30
Open-ended stock repurchase program unanimously approved by the boardAims to create shareholder value by growing Net Asset Value per Share (NAV/share), including in times of heightened volatilityTON Strategy Company
09-03 21:22